ConductScience.org, home

Trial · NCT06643871

Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

NCT06643871, Not applicable, Unknown, Centre Hospitalier St Anne

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis. Trials, record NCT06643871. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06643871

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis
NCT number
NCT06643871
Status
Unknown
Phases
Not applicable
Enrollment
40 participants, estimated
Lead sponsor
Centre Hospitalier St Anne
Conditions
Schizophrenia; Psychosis, Schizo Affective Disorder, First Episode Psychosis (FEP)
Interventions
Adapted physical activity program involving connected bikes
First posted
2024-10-16
Last updated
2024-10-16

Source ClinicalTrials.gov

Registered outcomes34

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCompletion rate of the DYNAMO-PSY programFrom enrollment to the end of the program at 15 weeks
The main objective will be to assess the completion rate of the dynamopsy program. Then, the primary outcome measure will be the completion of the program by the participant (Yes/No). For each patient included in the study, the number of sessions completed will be recorded. The DYNAMO-PSY program consists of 20 sessions in total. The DYNAMO-PSY program is considered completed when the patient has completed 20 sessions (otherwise, the program is considered abandoned). The completion rate to the DYNAMO-PSY program will be calculated as the proportion : number of patients who completed the program / number of patients included in the study.
SecondarySocial and Occupational Functioningat enrollment and at 15 weeksTotal score at SOFAS (Social and Occupational Functioning Assessment Scale)
SecondaryGlobal Functionningat enrollment and at 15 weeksTotal score at Global Assessment of Functioning (GAF) scale
SecondaryExecutive functions - Inhibitionat the enrollment and at 15 weeksScore at Stroop Test
SecondaryExecutive functions : Cognitive flexibilityat the enrollment and at 15 weeksScore at Trail Making Test
SecondaryExecutive functions - symptoms inventoryat the enrollment and at 15 weeksComposite executive globale Score (CEG) at the BRIEF questionnaire ( Behavior Rating Inventory of Executive Function ). Questionnaire fulfilled by the patient himself.
SecondaryMemory : Digit Spanat enrollment and at 15 weeksTotal score at Digit Span task
SecondaryMemory : visuospatial working memoryat enrollment and at 15 weeksTotal score at Corsi block - taping task
SecondaryMemory : Episodic memoryat enrollment and at 15 weeksTotal Score at MEM III task
SecondaryMemory : Processing speed (visual perception)at enrollment and at 15 weeksTotal score at Symbol Search task

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests7

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Corsi Block-Tapping TestSecondary outcomeConductCognition
Digit Span TestSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Symbol Scan TaskSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition
Verbal LearningSecondary outcomeConductCognition

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06643871

GET https://conductscience.org/api/trials/v1/NCT06643871/registered?page=2